301507 Hangzhou Minsheng Healthcare
- 12.88
- -0.30-2.28%
Hangzhou Minsheng Healthcare News
Minsheng Health (301507.SZ): Currently, it does not involve the production of APIs, nor does it involve the production of synthetic biological APIs
Gelonghui, May 8 | Minsheng Health (301507.SZ) said on the investor interactive platform that the company focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating R&D, production and sales of vitamin and mineral non-prescription drugs and health foods. Currently, the products sold by the company are mainly vitamin and mineral supplement series products. Please refer to the instructions for each product for specific product functions, product efficacy ingredients, and product application groups. The company is currently not involved in the production of APIs, nor is it involved in the production of synthetic biological APIs.
Minsheng Health (301507.SZ): Net profit of 58.7723 million yuan in the first quarter increased by 6.51% year-on-year
On April 23, Ge Longhui | Minsheng Health (301507.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 235 million yuan, up 5.78% year on year; net profit attributable to shareholders of listed companies was 588.723 million yuan, up 6.51% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 57.0676 million yuan, up 3.95% year on year; basic earnings per share were 0.1,700 yuan.
Minsheng Health (301507.SZ): Focus on the field of vitamin and mineral supplements
Gelonghui, April 17 | Minsheng Health (301507.SZ) said on the investor interactive platform that the company focuses on the field of vitamin and mineral supplements, and currently sells mainly vitamin and mineral supplement series products.
Minsheng Health (301507.SZ): The ban on 4.593 million restricted shares will be lifted on March 5
Gelonghui, February 28, 丨 Minsheng Health (301507.SZ) announced an indicative announcement on the listing and circulation of restricted shares for the initial public offering. The total number of shareholders whose sales restrictions have been lifted is 6,951, and the number of shares that have been lifted is 4,593 million shares, accounting for 1.29% of the company's total share capital. The sales restriction period is 6 months from the date of the company's initial public offering and listing. The stock listing and circulation date for which sales restrictions have been lifted is March 5, 2024 (Tuesday).
Minsheng Health (301507.SZ): 2023 net profit pre-increased 6.35%-11.42%
Gelonghui, January 15, 丨 Minsheng Health (301,507.SZ) announced its 2023 annual results forecast, with operating income of 58,000,000 yuan to 60,000,000 yuan, an increase of 6.01% to 9.67% over the same period of the previous year; net profit attributable to shareholders of listed companies was 84.0 million yuan - 88.0 million yuan, an increase of 6.35% to 11.42% over the same period of the previous year; net profit profit after deducting non-recurring profit and loss of 74.0 million yuan to 80.2 million yuan over the same period of the previous year 5.28% —16.66
People's Livelihood and Health (301507.SZ): The probiotic series has now been mass-produced
Glonghui, December 25|Some investors asked Minsheng Health (301507.SZ) on the investor interactive platform, “Is the probiotic series now mass-produced?” The company replied that the company's probiotic series has now been mass-produced and is produced and sold through Zhejiang Minsheng Health Technology Co., Ltd., a wholly-owned subsidiary.
Minsheng Health (301507.SZ): A business partnership with Ali Health Pharmacy
Glonghui December 7: Some investors asked Minsheng Health (301507.SZ) on the investor interactive platform, “Does the company cooperate with Ali Health?” The company replied that the company has a business partnership with Ali Health Pharmacy. The company won the “Ali Health Pharmacy Reputation Brand of the Year” and the “Ali Health Golden Deer Award” in 2020, the “Ali Health Golden Deer Award - Best Reputation Award” in 2021, and the “Ali Health Golden Deer Award - Innovative Brand Award” in 2022.
People's Livelihood and Health (301507.SZ): Currently, the company's products on sale are mainly vitamin and mineral supplement series products
On December 7, Gelonghui (301507.SZ) stated on the interactive platform that the company focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating R&D, production and sales of non-prescription drugs and health foods such as vitamins and minerals. Currently, the products sold by the company are mainly vitamin and mineral supplement series products. Please refer to each product manual for specific product functions, product efficacy ingredients, and product application groups.
Minsheng Health (301507.SZ) released results for the first three quarters, with net profit of 81.6723 million yuan, an increase of 9.12%
Minsheng Health (301507.SZ) released its report for the third quarter of 2023. The company's revenue for the first three quarters was 4...
People's Health (301507.SZ): Minoxidil liniment is one of the products being developed by the company and is not yet on the market
GLONGHUI, Oct. 11丨Some investors asked Minsheng Health (301507.SZ) on the investor interactive platform, “Are the company's anti-hair loss and hair regrowth products on the market? Where can I buy it?” The company said that minoxidil liniment is one of the products it is developing and has not yet been marketed. For R&D progress and estimated listing time, please refer to the relevant information already disclosed in the prospectus. Please check the product manual for specific product features at that time.
People's Health (301507.SZ): “Highly stable multi-encapsulated microcapsule powder, its preparation method and vitamin capsule” obtained an invention patent
Glonghui, Oct. 9, 丨 Minsheng Health (301507.SZ) announced that recently, Hangzhou Minsheng Health Pharmaceutical Co., Ltd. and Zhejiang Minsheng Health Technology Co., Ltd., a wholly-owned subsidiary of the company, received an invention patent certificate issued by the State Intellectual Property Office. It is a highly stable multi-encapsulated microcapsule powder, its preparation method and vitamin capsule.
Midday announcement: ST Tianshun's controlling shareholder plans to change control and the counterparty belongs to the local government industrial management group
Glonghui September 25 | At noon, a number of listed companies issued announcements: ① ST Tianshun: Controlling shareholder Zhoushan Tianshun Equity Investment Co., Ltd. is planning important matters related to the change in control of the company. The counterparty of this transaction belongs to a local government industrial management group, which is mainly engaged in investment and operation in the trade and logistics industry. The company's stock trading has been suspended since the opening of the market on September 25, and is expected to be suspended for no more than 2 trading days. ② Xinbo Co., Ltd.: Xinbo New Energy, a subsidiary of the company, recently received model designation notifications from some domestic customers. Xinbo New Energy was selected by the above customers to separately provide the battery case, threshold beam, aluminum extender adapter bracket, and front cabin frame
People's Livelihood and Health (301507.SZ): The amount of proposed investment in production buildings and supporting facilities expansion projects using its own capital is estimated to be 150 million yuan
Glonghui, September 25, 丨 Minsheng Health (301507.SZ) announced that the company held the 12th meeting of the first board of directors on September 22, 2023 to review and pass the “Proposal on Proposed Use of Own Funds to Invest in Production Buildings and Supporting Facilities Expansion Projects”. In order to further improve the company's existing land utilization rate and reduce related costs, the company plans to expand the production building and supporting facilities at the existing site. The project investment amount is estimated at 149.6034 million yuan. The purpose of this expansion project is to maximize the use of the company's existing land resources, reduce related costs, and at the same time focus on the company's development plan in the long term
People's Health (301507.SZ): The company currently has no medical qualifications
GLONGHUI, September 6丨Minsheng Health (301507.SZ) stated on the investor interactive platform that the company currently has no medical qualifications.
Express News | Minsheng Health, a leading domestic vitamin company, successfully entered the GEM.
Minsheng Healthcare Soars 240% in Shenzhen Trading Debut
Hangzhou Minsheng Healthcare (SHE:301507) soared 240% Tuesday morning when it debuted on the Shenzhen Stock Exchange's ChiNext board. Shares of the Chinese manufacturer and distributor of medical prod
A-share IPO News: Minsheng Health (301507.SZ) is listed today
GLONGHUI September 5 | Wande Co., Ltd. (836419) was purchased today, and Minsheng Health (301507.SZ) was listed today.
Minsheng Health (301507.SZ) will be listed on GEM on September 5
Minsheng Health (301507.SZ) announced that the company's shares will be traded in Shenzhen Securities on September 5, 2023...
After Minsheng Health (301507.SZ) was called back, the winning rate for online distribution was 0.0383%
Minsheng Health (301507.SZ) announced that the number of valid applicants for the company's initial public offering of shares online is 8...
Minsheng Healthcare Opens Books For 891 Million Yuan Shenzhen IPO
Hangzhou Minsheng Healthcare (SHE:301507) has started taking subscriptions for its 891.4 million yuan initial public offering on the Shenzhen Stock Exchange's ChiNext board. The Chinese manufacturer a
Analysis
Price Target
No Data
